Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 22nd November 2022

    ARECOR TO COMMENCE SECOND CLINICAL TRIAL WITH AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN CANDIDATE FOR TYPE 2 DIABETES

  • 22nd November 2022

    ARECOR GRANTED KEY PATENT IN JAPAN AND SOUTH KOREA TO PROTECT PROPRIETARY INSULIN PRODUCTS AT247 AND AT278

  • 10th November 2022

    ARECOR ANNOUNCES EXCLUSIVE SPECIALTY HOSPITAL FORMULATION COLLABORATION